AIDS
- GIANELLA S, Anderson C, Chaillon A, Wells A, et al
Impact of influenza and pneumococcal vaccines on HIV persistence and immune
dynamics during suppressive antiretroviral therapy.
AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
Ann Intern Med
- WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination
Campaigns in the United States.
Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
BMJ
- MAHASE E
Covid-19: Pfizer vaccine to be available privately at pharmacy chain Boots from
April.
BMJ. 2024;384:q762.
Clin Infect Dis
- ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and
Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017
A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03
Adjuvant in Healthy US
Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
J Gen Virol
- SAMOLEJ J, White IJ, Strang BL, Mercer J, et al
Cardiac glycosides inhibit early and late vaccinia virus protein expression.
J Gen Virol. 2024;105.
J Infect Dis
- KAO CM, Rostad CA, Nolan LE, Peters E, et al
A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the
Safety and Immunogenicity of HEV-239 (Hecolin(R)) Vaccine in Healthy US Adults.
J Infect Dis. 2024 Mar 27:jiae148. doi: 10.1093.
- KALIZANG'OMA A, Swarthout TD, Mwalukomo TS, Kamng'ona A, et al
Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant
Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent
Pneumococcal Conjugate Vaccine Introduction.
J Infect Dis. 2024 Mar 26:jiae040. doi: 10.1093.
J Virol
- WU K, Hou YJ, Makrinos D, Liu R, et al
Characterization of humoral and cellular immunologic responses to an mRNA-based
human cytomegalovirus vaccine from a phase 1 trial of healthy adults.
J Virol. 2024 Mar 25:e0160323. doi: 10.1128/jvi.01603.
- JOSHI VR, Claiborne DT, Pack ML, Power KA, et al
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1
envelope.
J Virol. 2024 Feb 27:e0172023. doi: 10.1128/jvi.01720.
- SHINGAI M, Iida S, Kawai N, Kawahara M, et al
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon
influenza virus infection by subtraction of the background antibody repertoire.
J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
JAMA
- HARRIS E
WHO Issues First Recommendations for Managing Diphtheria.
JAMA. 2024;331:907.
Lancet
- BURKI T
Pivotal tuberculosis vaccine trial begins.
Lancet. 2024;403:1125.
MMWR Morb Mortal Wkly Rep
- LINK-GELLES R, Rowley EAK, DeSilva MB, Dascomb K, et al
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines
Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with
Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
Nat Med
- O'LEARY K
Going the extra mile to increase vaccine uptake.
Nat Med. 2024 Mar 28. doi: 10.1038/d41591-024-00022.
- RAPPAPORT AR, Kyi C, Lane M, Hart MG, et al
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced
metastatic solid tumors: phase 1 trial interim results.
Nat Med. 2024 Mar 27. doi: 10.1038/s41591-024-02851.
Pediatr Infect Dis J
- SENDERS S, Klein NP, Tamimi N, Thompson A, et al
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of
20-valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004334.
Pediatrics
- DALAPATI T, Williams CA, Giorgi EE, Hurst JH, et al
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children Less
Than 5 Years of Age.
Pediatrics. 2024 Mar 29. doi: 10.1542/peds.2024-066190.
- GAVIRIA-AGUDELO C, Yonts AB, Kimberlin DW, Campbell JD, et al
February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other
Vaccines.
Pediatrics. 2024 Mar 29. doi: 10.1542/peds.2024-066653.
PLoS One
- PAUDEL S, Apostolakos I, Vougat Ngom R, Tilli G, et al
A systematic review and meta-analysis on the efficacy of vaccination against
colibacillosis in broiler production.
PLoS One. 2024;19:e0301029.
- DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
Association of anti-diabetic drugs and covid-19 outcomes in patients with
diabetes mellitus type 2 and chronic kidney disease: Nationwide registry
analysis.
PLoS One. 2024;19:e0301056.
- BRAY LA, Jervis LL, Janitz AE, Ross L, et al
Toward trustworthy COVID-19 interventions: Building vaccine trust through
community-university partnerships.
PLoS One. 2024;19:e0300872.
- AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
Impact of COVID-19 vaccination on liver transplant recipients. Experience in a
reference center in Mexico.
PLoS One. 2024;19:e0301198.
Science
- MICHEL AL
Vaccines to control tuberculosis in cattle.
Science. 2024;383:1410-1411.
- FROMSA A, Willgert K, Srinivasan S, Mekonnen G, et al
BCG vaccination reduces bovine tuberculosis transmission, improving prospects for
elimination.
Science. 2024;383:eadl3962.
Vaccine
- FUKUDA Y, Suzuki T, Iwata KI, Haruta K, et al
Nanopore sequencing in distinguishing between wild-type and vaccine strains of
Varicella-Zoster virus.
Vaccine. 2024 Mar 27:S0264-410X(24)00333-5. doi: 10.1016/j.vaccine.2024.
- BRUUN N, Laursen MF, Carmelo R, Christensen E, et al
Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic
cells and generate a potent antibody response in vivo.
Vaccine. 2024 Mar 26:S0264-410X(24)00364-5. doi: 10.1016/j.vaccine.2024.
- ZHAO Z, Meng Q, Sun TZ, Zhu B, et al
Mannose modified targeted immersion vaccine delivery system improves protective
immunity against Infectious spleen and kidney necrosis virus in mandarin fish
(Siniperca chuatsi).
Vaccine. 2024 Mar 21:S0264-410X(24)00335-9. doi: 10.1016/j.vaccine.2024.
- KLUWER B, Gleditsch R, Rydland KM, Mamelund SE, et al
Higher educational attainment associated with higher confidence in influenza
vaccination in Norway.
Vaccine. 2024 Mar 21:S0264-410X(24)00338-4. doi: 10.1016/j.vaccine.2024.
- ZHANG Y, Wang Y, Li G, Zhao X, et al
A randomized, blind, parallel controlled phase I clinical trial to evaluate the
safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide
vaccine in healthy people aged 2 years and older.
Vaccine. 2024 Mar 21:S0264-410X(24)00331-1. doi: 10.1016/j.vaccine.2024.
- HIRTH J, Ostovar-Kermani T, Gutierrez JA, Thompson EL, et al
Effect of age at initiation of the human papillomavirus vaccine on the
association between race/ethnicity and completion of the vaccine series.
Vaccine. 2024 Mar 21:S0264-410X(24)00336-0. doi: 10.1016/j.vaccine.2024.
- PRICE O, Dietze P, Maher L, Dore GJ, et al
High COVID-19 vaccine uptake following initial hesitancy among people in
Australia who inject drugs.
Vaccine. 2024 Mar 21:S0264-410X(24)00337-2. doi: 10.1016/j.vaccine.2024.
- COMES JDG, Doets K, Zegers T, Kessler M, et al
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens.
Vaccine. 2024 Mar 22:S0264-410X(24)00319-0. doi: 10.1016/j.vaccine.2024.
- CONDIE J, Northstone K, Major-Smith D, Halstead I, et al
Exploring associations between the Big Five personality traits and cognitive
ability with COVID-19 vaccination hesitancy and uptake among mothers and
offspring in a UK prospective cohort study.
Vaccine. 2024 Mar 22:S0264-410X(24)00305-0. doi: 10.1016/j.vaccine.2024.
- STUREBORG R, Nichols J, Dhingra B, Yang J, et al
Development and validation of VaxConcerns: A taxonomy of vaccine concerns and
misinformation with Crowdsource-Viability.
Vaccine. 2024 Mar 22:S0264-410X(24)00255-X. doi: 10.1016/j.vaccine.2024.
- MORGAN G, Casalino S, Chowdhary S, Frangione E, et al
COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study.
Vaccine. 2024 Mar 22:S0264-410X(24)00317-7. doi: 10.1016/j.vaccine.2024.
- PONNE S, Kumar R, Vanmathi SM, Brilhante RSN, et al
Reverse engineering protection: A comprehensive survey of reverse
vaccinology-based vaccines targeting viral pathogens.
Vaccine. 2024 Mar 23:S0264-410X(24)00265-2. doi: 10.1016/j.vaccine.2024.
- DAHL BA, Tritter B, Butryn D, Dahlke M, et al
Global VAX: A U.S. contribution to global COVID-19 vaccination efforts,
2021-2023.
Vaccine. 2024 Mar 23:S0264-410X(24)00359-1. doi: 10.1016/j.vaccine.2024.
- VOLKMANN AM, Goldin S, McMurren B, Gapare C, et al
Leveraging seasonal influenza health worker vaccination programmes for COVID-19
vaccine Introduction: A global qualitative analysis.
Vaccine. 2024 Mar 25:S0264-410X(23)01490-1. doi: 10.1016/j.vaccine.2023.
- BIEGUS J, Szenborn L, Zymlinski R, Zakliczynski M, et al
The early safety profile of simultaneous vaccination against influenza and
Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure.
Vaccine. 2024 Mar 25:S0264-410X(24)00366-9. doi: 10.1016/j.vaccine.2024.
- DALEY MF, Reifler LM, Shoup JA, Glanz JM, et al
Influenza vaccination accuracy among adults: Self-report compared with electronic
health record data.
Vaccine. 2024 Mar 25:S0264-410X(24)00339-6. doi: 10.1016/j.vaccine.2024.
- WEYANT C, Hooda Y, Munira SJ, Lo NC, et al
Cost-effectiveness and public health impact of typhoid conjugate vaccine
introduction strategies in Bangladesh.
Vaccine. 2024 Mar 25:S0264-410X(24)00322-0. doi: 10.1016/j.vaccine.2024.
- PARISI A, Nunez O, Lopez-Perea N, Masa-Calles J, et al
Reduced pertussis disease severity in infants following the introduction of
pertussis vaccination of pregnant women in Spain, 2015-2019.
Vaccine. 2024 Mar 25:S0264-410X(24)00315-3. doi: 10.1016/j.vaccine.2024.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016